pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
Endpoints·May 13·1 min read
save

Merck KGaA's clients are stockpiling due to Iran war, supporting guidance boost

Merck KGaA appears to have a big-picture view of how the Iran war is affecting the pharma industry so far. The German company is seeing an uptick in demand for its lab equipment products as ...

May 13, 2026·read at Endpoints ↗

Helene von Roeder, Merck KGaA CFO (Arne Dedert/picture-alliance/dpa/AP Images) May 13, 2026 07:01 AM EDT PharmaManufacturing Mer­ck KGaA's clients are stock­pil­ing due to Iran war, sup­port­ing guid­ance boost Anna Brown News Reporter Mer­ck KGaA ap­pears to have a big-pic­ture view of how the Iran war is af­fect­ing the phar­ma in­dus­try so far. The Ger­man com­pa­ny is see­ing … Sign up to read this article for free. Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER

source

Reporting by Endpoints.

read at Endpoints ↗
92 words · retrieved May 13
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

companies
Merck KGaA3

related stories

  • 8h agoNovartis may cut around 130 in Switzerland while relocating biologics productionBioSpace
  • Aug 21Werewolf transforms into Ambros via reverse merger to support phase 3 push for rare disease drugFierce Biotech
  • Aug 20Out of sight, out of work? What’s driving remote job cutsBioSpace
  • Aug 17Merck KGaA lays off 20 staffers in latest blow to US research teamFierce Biotech
  • Aug 17Lilly pens $370M deal with OmniAb for ion channel collab, but details remain vagueFierce Biotech